Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe | Orphanet Journal of Rare Diseases | Full Text

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe | Orphanet Journal of Rare Diseases | Full Text

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to prov...

Authors:Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Christoph Sowada, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar and Marian Sorin Paveliu

Citation:Orphanet Journal of Rare Diseases 2020 15:277

Content type:Research

 

Published on: 8 October 2020

• ViewFull Text
 
• ViewPDF